Bivalirudin in Peripheral Interventions

Techniques in Vascular and Interventional Radiology

Volumn 9, Issue 2, 2006, Pages 80-83

  MacLean, Alexandra A ^a   Peña, Constantino S ^b   Katzen, Barry T ^b  

^a NEW YORK HOSPITAL QUEENS   (United States)

^b BAPTIST CARDIAC AND VASCULAR INSTITUTE   (United States)

Author keywords

bivalirudin; direct thrombin inhibitors; peripheral interventions

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ARGATROBAN; ENOXAPARIN; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HIRUDIN; HIRULOG; LOW MOLECULAR WEIGHT HEPARIN; MELAGATRAN; WARFARIN;

ACUTE CORONARY SYNDROME; ANGIOPLASTY; ANTICOAGULATION; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY STENT; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFICACY; DRUG FATALITY; DRUG HALF LIFE; DRUG MEGADOSE; DRUG MONITORING; DRUG SAFETY; DRUG TOLERABILITY; EMBOLISM; HEART INFARCTION; HEMATOMA; HUMAN; INTERMETHOD COMPARISON; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; ISCHEMIA; LOW DRUG DOSE; MONOTHERAPY; PERCUTANEOUS CORONARY INTERVENTION; RANDOMIZED CONTROLLED TRIAL; REVASCULARIZATION; STROKE; THROMBOCYTOPENIA; THROMBOSIS; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS;

ANTICOAGULANTS; HIRUDINS; HUMANS; PEPTIDE FRAGMENTS; RADIOLOGY, INTERVENTIONAL; RECOMBINANT PROTEINS;

EID: 34247601592     PISSN: 10892516     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.tvir.2006.12.007     Document Type: Article

References (17)

1. Messmore H.L., Wehrmacher W.H., Coyne E., et al. Heparin to pentasaccharide and beyond: the end is not in sight. Semin Thromb Hemost 30 suppl 1 (2004) 81-88
2. Shammas N.W. An overview of antithrombins in peripheral vascular interventions. J Invasive Cardiol 16 8 (2004) 440-443
3. Lincoff A.M., Bittl J.A., Kleiman N.S., et al. Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the randomized evaluation of PCI linking angiomax to reduced clinical events [REPLACE]-1 trial). Am J Cardiol 93 9 (2004) 1092-1096
4. Shammas N.W., Lemke J.H., Dippel E.J., et al. Bivalirudin in peripheral vascular interventions: a single center experience. J Invasive Cardiol 15 7 (2003) 401-404
5. Allie D.E., Lirtzman M.D., Wyatt C.H., et al. Bivalirudin as a foundation anticoagulant in peripheral vascular disease: a safe and feasible alternative for renal and iliac interventions. J Invasive Cardiol 15 6 (2003) 334-342
6. Katzen B.T., Ardid M.I., MacLean A.A., et al. Bivalirudin as an anticoagulant agent: safety and efficacy in peripheral interventions. J Vasc Interv Radiol 16 (2005) 1183-1187
7. Allie D.E., Hall P., Shammas N.W., et al. The angiomax peripheral procedure registry of vascular events trial (APPROVE): in-hospital and 30-day results. J Invasive Cardiol 16 11 (2004) 651-656
8. Bittl J.A., Chaitman B.R., Feit F., et al. Bivalirudin versus heparin during coronary angioplasty for unstable or postinfarction angina: final report reanalysis of the bivalirudin angioplasty study. Am Heart J 142 (2001) 952-959
9. Lincoff A.M., Kleiman N.S., Kottke-Marchant K., et al. Bivalirudin with planned or provisional abciximab versus low-dose heparin and abciximab during percutaneous coronary revascularization: results of the comparison of abciximab complications with hirulog for ischemic events trial (CACHET). Am Heart J 143 (2002) 847-853
10. Lincoff A.M., Bittl J.A., Harrington R.A., et al. Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial. JAMA 289 7 (2003) 853-863
11. Stone G.W., McLaurin B.T., Cox D.A., et al. Bivalirudin for patients with acute coronary syndromes. N Engl J Med 355 21 (2006) 2203-2216
12. Nikolsky E., and Dangas G.D. Percutaneous interventions in patients with immune-mediated heparin-induced thrombocytopenia. Semin Thromb Hemostasis 30 3 (2004) 305-314
13. Mahaffey K.W., Lewis B.E., Wildermann N.M., et al. The anticoagulant therapy with bivalirudin to assist in the performance of percutaneous coronary intervention in patients with heparin-induced thrombocytopenia (ATBAT) study: main results. J Invasive Cardiol 15 (2003) 611-616
14. Cochran K., DeMartini T.J., Lewis B.E., et al. Use of lepirudin during percutaneous vascular interventions in patients with heparin-induced thrombocytopenia. J Invasive Cardiol 15 (2003) 617-621
15. Lewis B.E., Matthai Jr. W.H., Cohen M., et al. Argatroban anticoagulation during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia. Catheter Cardiovasc Interv 57 (2002) 177-184
16. Mahaffey K.W. Anticoagulation for acute coronary syndromes and percutaneous coronary intervention in patients with heparin-induced thrombocytopenia. Curr Cardiol Rep 3 5 (2001) 362-370
17. Grubbs G. Anticoagulation in peripheral interventions. Endovascular Today (2003) 1-4